Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-055208
Filing Date
2006-03-15
Accepted
2006-03-15 17:32:14
Documents
11
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1231773
2 SUMMARY OF DIRECTOR COMPENSATION dex106.htm EX-10.6 3605
3 FORM OF SEVERANCE PAYMENT AGREEMENT dex1012.htm EX-10.12 37318
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1975
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9624
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9667
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3308
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C SECTION 1350 dex322.htm EX-32.2 3305
10 GRAPHIC g32165g68f00.jpg GRAPHIC 37125
11 GRAPHIC g32165g96y73.jpg GRAPHIC 43159
12 GRAPHIC g32165wilmerhale1.gif GRAPHIC 1528
  Complete submission text file 0001193125-06-055208.txt   1415042
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Filer) CIK: 0000902622 (see all company filings)

EIN.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50676 | Film No.: 06689286
SIC: 2834 Pharmaceutical Preparations